Field Safety Notices about HeartMate II® System Controller

According to Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), this field safety notices involved a device in Slovenia that was produced by Thoratec Corporation.

What is this?

Field safety notices are communications sent out by medical device manufacturers or their representatives in relation to actions that they may be taking in relation to their product that is on the market. These are mainly for health workers, but also for users. They can include recalls and alerts.

Learn more about the data here
  • Type of Event
    Field Safety Notice
  • Date
  • Event Country
  • Event Source
  • Notes / Alerts
    Data from Slovenia is current through February 2019. All of the data comes from the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Slovenia.
  • Extra notes in the data
  • Reason
    As part of the follow-up to our last message in september 2015, we remind you that thoratec corporation, part of the abbott laboratories group, is updating its alerts, upgrading software, and adding heartmate ii® system controller alignment tags as part of an ongoing effort to be able to emergency patients successfully replaced their pocket controller.   in 2014, several improvements were made to training and education following the voluntary introduction of revisions to the patient controller replacement process. as a consequence, we found that the rate of adverse events in system controller replacements decreased by 80%. as many as 90% of the system controller controls that were previously replaced at home are now replaced in the hospital, according to the operating instructions. nevertheless, patients still experience a very low rate of side effects (including severe injury or death) in 0.1% of the total, which is due to unnecessary replacement of the patient's controllers. it is best if system controller replacements are performed by health care personnel in a controlled environment.



  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source